Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Movement Characterization in Spastic/Dystonic Cerebral Palsy Using Haptic Feedback in Virtual Reality

31 décembre 2019 mis à jour par: Citlali Lopez-Ortiz, University of Illinois at Urbana-Champaign

Movement Impairment Characterization and Rehabilitation for Spastic/Dystonic Cerebral Palsy Using Robotic Haptic Feedback in Virtual Reality

This game-like intervention using virtual reality will provide an objective and quantitative characterization of dystonia and spasticity presentations in cerebral palsy, even if combined, through the process of motor learning. This intervention could have a therapeutic benefit in the rehabilitation of children with cerebral palsy.

Aperçu de l'étude

Description détaillée

Cerebral palsy is the most common developmental motor disorder in children. Individuals with cerebral palsy demonstrate abnormal muscle tone and motor control. Within the population of children with cerebral palsy, between 4% and 17% present dystonic symptoms and between 80% to 95% of cases present spasticity. In many cases spasticity and dystonia are present in the same child and accurate diagnosis may be challenging.

This study consists of a randomized controlled trial that uses a virtual reality game-based intervention incorporating fully-automated robotic haptic feedback to aid the the objective, quantitative diagnosis of spasticity and dystonia u=in CP. The study consists of face-to-face assessments of movement before, after, and one-month following the completion of the six-session game-based intervention. Children with spastic/dystonic cerebral palsy and typically developing children between the ages of 7 and 17 will be recruited for this study. The investigators anticipate to recruit a total of 68 participants, 34 with cerebral palsy and 34 typically developing. Both groups of children will be randomly allocated into an intervention or control group using a blocked randomization method. Movement outcomes will be examined for changes in quantitative and clinical measures in children with spastic/dystonic cerebral palsy and typically developing children to aid on the classification of movement disorders. Pair t-tests will be conducted on movement outcomes for both groups of children independently. Positive and negative results will be reported and addressed.

Type d'étude

Interventionnel

Inscription (Anticipé)

68

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Illinois
      • Urbana, Illinois, États-Unis, 61801
        • Recrutement
        • University of Illinois at Urbana-Champaign
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

7 ans à 17 ans (Enfant)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Between ages 7 and 17
  • Have been diagnosed with dystonic or spastic/dystonic cerebral palsy, for the cerebral palsy groups, or have no neuromuscular conditions, for typically developing groups
  • Have mild to no difficulty understanding conversations compared to others of the same age
  • Communicates age appropriately or with some difficulty but a new listener can understand
  • Have no uncorrected vision
  • Have hearing without the need of a hearing aid
  • Have no other neural, neuromuscular, or musculoskeletal conditions
  • Participation in stable school and/or private physical or occupational therapy with a frequency no greater than two sessions per week, for cerebral palsy groups
  • Have no changes in medication for the six months previous to enrollment in the study
  • Be medically stable
  • Have no other concurrent illness
  • Have not received any Botox treatment within three months previous to the initiation of the study
  • No use of cardiac pacemakers, hearing aids, or another electronic implanted device
  • Absence of allergy to silver or skin adhesives
  • Have never had seizures
  • Have Manual Ability Classification System (MACS) score I-III

Exclusion Criteria:

  • Not meeting ALL inclusion criteria

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Diagnostique
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: CP intervention group
Force efforts with haptic feedback in virtual reality for participants with CP.
A virtual reality game-based intervention incorporating fully-automated robotic haptic feedback. The study consists of face-to-face assessments of movement before, after, and one-month following the completion of the six-session game-based intervention. Children with spastic/dystonic cerebral palsy between the ages of 7 and 17 will be recruited for this study along with a group of typically developing children in the same age range. Both groups of children will be randomly allocated into an intervention or control group using a blocked randomization method.
Aucune intervention: CP control group
Regular activity control group, for participants with CP.
Expérimental: TD intervention group
Force efforts haptic feedback in virtual reality. The intervention will be the same as the CP intervention group but for typically developing participants.
A virtual reality game-based intervention incorporating fully-automated robotic haptic feedback. The study consists of face-to-face assessments of movement before, after, and one-month following the completion of the six-session game-based intervention. Children with spastic/dystonic cerebral palsy between the ages of 7 and 17 will be recruited for this study along with a group of typically developing children in the same age range. Both groups of children will be randomly allocated into an intervention or control group using a blocked randomization method.
Aucune intervention: TD control group
Regular activity control group, same as CP no intervention group, but for typically developing participants.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Smoothness Index
Délai: Tested during the assessment sessions spanning over a 6 to 7 week period.

The smoothness index will be measured by analyzing the the integrated accelerometry signals of sensors placed on the upper limbs. Accelerometry data will be integrated to calculate the smoothness index on the velocity profile of the trajectories.

The maximum value is 0, being the greatest level of smoothness that can be measured, and the minimum is minus infinity. A value closer to 0 is desired.

Tested during the assessment sessions spanning over a 6 to 7 week period.

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Surface electromyography
Délai: Tested during the assessment sessions and on the first and last day of gameplay spanning over a 6 to 7 week period.
Surface electromyography (sEMG) data will be collected during the execution of a first port de bras. The first port de bras will follow the format from the Royal Academy of Dance as demonstrated (Figure 1). Data will be analyzed changes in muscle activity patterns as a secondary outcome measure. The sEMG data will also be acquired during maximum voluntary efforts. For calibration of game-playing.
Tested during the assessment sessions and on the first and last day of gameplay spanning over a 6 to 7 week period.
Forces and torques against force sensor during gampeplay and in robotic zero-force channel
Délai: Tested during the assessment sessions and on the first and last day of gameplay spanning over a 6 to 7 week period.
This involves a force/torque sensor mounted in the end effector of the robot. A pre-determined zero-force path has been programmed by the research team to allow the robot to move through straight lines connected to five points on a vertical plane. The participants will hold a gripper mounted on the force transducer and attempt to move the end effector of the robot along the zero-force path. The force transducer will measure the forces exerted by the participant as they do so. Force and torque signals will be collected during all game-playing sessions. The calibration for game playing involves a maximum voluntary effort by the participant's dominant arm against the sensor mounted on a sturdy table. Participants will also be assessed with the force sensor in fourteen different directions at 30% ± 10% of the maximal voluntary effort across all directions.
Tested during the assessment sessions and on the first and last day of gameplay spanning over a 6 to 7 week period.
Montreal Spasticity Rating Test (MSRT)
Délai: Tested during the assessment sessions spanning over a 6 to 7 week period.
The MSRT is a quantitative measure the onset of the stretch reflex that that correlates with clinical spasticity and shows good test re-test reliability
Tested during the assessment sessions spanning over a 6 to 7 week period.
Dyskinesia Impairment Scale (DIS)
Délai: Tested during the assessment sessions spanning over a 6 to 7 week period.
The Dyskinesia Impairment Scale (DIS) measures the severity of dystonia and choreoathetosis when an individual is at rest or moving. It was found to show good to excellent reliability and validity. Scores range from 0 to 4 for both duration and amplitude of each criterion. A score of 0 most corresponds to movement of healthy people without movement disorders. The highest score possible score is 576 indicating the most server level of impairs,ent. There are two sub scales: Dystonia and Choreoathetosis that have a range of 0-288 each. The total score is obtained by addition of the two subscores.
Tested during the assessment sessions spanning over a 6 to 7 week period.
Selective Control of the Upper Extremity Scale (SCUES)
Délai: Tested during the assessment sessions spanning over a 6 to 7 week period.
The Selective Control of the Upper Extremity Scale (SCUES) is a video-based tool to measure selective control of upper limb tasks. Psychometric analysis shows "comparable validity to other accepted video-based clinical assessment tools for the upper extremity in children with CP " with content validity ratio values indicating substantial agreement for most items. Scores are assigned for each assessed joint and can be rated as M3, M2, M1, or M0 with M3 representing normal selective motor control and M0 representing no selective motor control.
Tested during the assessment sessions spanning over a 6 to 7 week period.
Quality of Upper Extremity Skills Test (QUEST)
Délai: Tested during the assessment sessions spanning over a 6 to 7 week period.

The QUEST is 36 items in length and measures upper limb movement, hand function, and cooperativeness in children with CP. It has been found to be reliable to assess children with CP between 18 months and 8 years of age, with increased reliability in children up to 12 years of age [30]. It has also been found to show adequate to excellent validity.

Initial scores range from 50 to 100, which are then standardized to be between 0 and 100. The initial score is summed by scoring the ability to complete an item according to specification as 2 points, not being able to, not willing to, or not administerable as 1 point, and minus 1 point for abnormal movement in the posture section of the assessment. The standardized score is found by dividing the sum of scores for each section tested by the total number of sections tested.

Tested during the assessment sessions spanning over a 6 to 7 week period.
Tardieu scale
Délai: Tested during the assessment sessions spanning over a 6 to 7 week period.

The Tardieu scale examines spasticity with quantified measures of the responses of stretch reflexes. This scale shows high test retest and poor to moderate inter-rater reliability; the Tardieu scale performs better than other similar measures, indicating it may be more reliable.

Scores of quality of muscle reaction range from 0 to 5 with 0 being no resistance throughout passive movement and 5 being an immobile joint.

Tested during the assessment sessions spanning over a 6 to 7 week period.
World Health Organization Disability Assessment Schedule 2 Children and Youth (WHODAS II - CY)
Délai: Tested during the assessment sessions spanning over a 6 to 7 week period.

The WHODAS II - CY is a self-report 36 item document that assesses daily issues surrounding health conditions such as illnesses, injuries, and problems with mental health. In a validity study, it was found to show good reliability; however, limitations regarding options for those without significant disabilities were present.

Each item can be scored from 1 to 5, with 1 indicating none and 5 indicating extreme or cannot do. Each item is scored, summed within the domain it is in, and the average is taken for each domain. The averages are summed and converted to a metric ranging from 0 to 100 where 0 indicates no disability and 100 indicating severe disability.

Tested during the assessment sessions spanning over a 6 to 7 week period.
Qualitative Feedback Module
Délai: Tested during the assessment sessions spanning over a 6 to 7 week period.
Multiple choice patient satisfaction questionnaire. Scores range from 0 to 5 for each item similar to the Wong-Baker FACES Pain Rating Scale with 0 indicating highest satisfaction and 5 indicating highest dissatisfaction.
Tested during the assessment sessions spanning over a 6 to 7 week period.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Citlali Lopez-Ortiz, University of Illinois at Urbana-Champaign

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 décembre 2018

Achèvement primaire (Anticipé)

1 janvier 2021

Achèvement de l'étude (Anticipé)

1 janvier 2021

Dates d'inscription aux études

Première soumission

26 octobre 2018

Première soumission répondant aux critères de contrôle qualité

15 novembre 2018

Première publication (Réel)

16 novembre 2018

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

3 janvier 2020

Dernière mise à jour soumise répondant aux critères de contrôle qualité

31 décembre 2019

Dernière vérification

1 décembre 2019

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner